Sidney Wong

Sidney Wong

Sidney Wong is the assistant vice president of policy at ISO Claims Partners, where he provides the highest level of client services—with a focus on meeting the needs of clients through ISO’s products and services. He is also responsible for assisting clients with effectively navigating Medicare compliance issues.

    Posts by Sidney Wong

    Making Sense of the WCMSA Reference Guide 2.6

    When the Centers for Medicare and Medicaid Services (CMS) released the latest Workers’ Compensation Medicare Set-Aside (WCMSA) Reference Guide on July 31, 2017, we anticipated more insights to new processes; but the new guide presents as many questions as it proposes to answer. Questions remain about how limits to WCMSA re-reviews will play out and […]

    Opana ER Will Be Removed from the Marketplace

    Opana ER will be voluntarily removed from the marketplace, per the announcement last week of manufacturer Endo International plc. This follows the FDA’s suggestion that we blogged about last month—and it is an important next step in the fight against opioid abuse. No date has been set to remove the medication, but we’re closely monitoring […]

    Shiny New Features for the WCMSA Portal

    The Centers for Medicare and Medicaid Services (CMS) recently released an updated Workers’ Compensation Medicare Set-Aside Portal (WCMSAP) manual in conjunction with substantial changes to the portal. The most significant change is a new WCMSA re-review request option — please find a comprehensive analysis of this change here. Features Affecting Beneficiaries Two portal changes are […]

    A Solid Second Bite: CMS Re-review Now Allows New Medical Documentation

    Yesterday, the Centers for Medicare and Medicaid Services (CMS) released a new Workers’ Compensation Medicare Set-Aside Portal (WCMSAP) User Guide and updated its re-review process to include a third option: re-reviews of WCMSA decisions based on significant treatment changes. Prior Options Precluded CMS from Considering Current Changes in Treatment CMS’ informal process had limited re-review […]

    FDA request to remove Opana ER may be good news for WCMSAs

    The FDA has recently intervened in the escalating fight against opioid abuse. The agency has requested that Opana ER, a long-acting opioid medication, be removed from the market due to the high risk of users crushing the pill to inject it. This manipulation of the medication has not only led to a higher risk of […]

    3 Easy Ways to Reduce MSA Prescription Costs

    With prescription prices increasing every day, it’s harder than ever to contain costs. That’s why we put together three easy ways to reduce Workers’ Compensation Medicare Set-Aside (WCMSA) costs.[1] 1. Split the difference on dosages Splitting higher dosages into multiple lower dosages can really cut costs. Take gabapentin, the generic form of Neurontin. Often prescribed […]